10/24/2025China NMPA Publishes 97th Batch of Reference Formulations for Generic...

10/22/2025Innovent and Takeda Ink $11.4B Oncology Alliance

10/22/2025Samsung Bioepis and Phrontline Forge Partnership to Co-Develop Next-Ge...

10/22/2025China's Aging Population to Drive Trillion-Dollar Healthcare Boom, UBS...

10/22/2025Multitude Reports Strong Efficacy for CD44v9-Targeted ADC AMT-116 at E...

10/22/2025Zai Lab Launches First Phase 3 Trial of DLL3-Targeted ADC ZL-1310 in R...

10/22/2025GenScript Wins NMPA IND Nod for Bispecific ADC GenSci139

10/22/2025Understanding China's Longevity Market: Industry Segments, Trends and ...

10/21/2025ESMO 2025 Highlights China's Strategic Leap in Oncology Innovation

10/21/2025Merck KGaA and Abbisko Report Strong Phase 3 Results for Pimicotinib a...

10/21/2025RemeGen's Disitamab Vedotin Plus Toripalimab Delivers Breakthru First-...

10/21/2025Sunnovo Invests in Byterna to Advance Circular mRNA

10/21/2025Riltide Completes Seed Financing to Advance AI-Driven Autoimmune Thera...

10/21/2025Kelun-Biotech's Sacituzumab Tirumotecan Shows Strong Phase 3 Results

10/21/2025CSPC's JSKN003 Granted Breakthru Therapy Designation in China

10/21/2025Henlius' PD-L1 ADC HLX43 Receives Orphan Drug Designation in the U.S.

10/20/2025Akeso Reports Strong China Data for Ivonescimab in Lung Cancer

10/20/2025Sanofi Launches €1B Insulin API Manufacturing Project in Beijing

10/20/2025CDE Seeks Comments on Implementation Recommendations and Chinese Tran...

10/20/2025CDE Solicits Comments on the Reference Formulations for Chemical Gener...

10/20/2025CDE Seeks Feedbacks on Draft Technical and Submission Requirements for...

10/20/2025China Accelerates Nationwide Rollout of Real-Time BMI Fund Settlement

10/20/2025Kelun Gains China Approval for First Homegrown HER2 Breast Cancer ADC

10/17/2025I-Mab to Rebrand as NovaBridge Biosciences and Pursue Hong Kong IPO

10/17/2025Roche Expands Oncology Pipeline Thru Global Licensing Deal with Hansoh...

10/17/2025Dianthus Secures Exclusive Global Rights to DNTH212 from China's Leads...

10/17/2025RemeGen's Telitacicept Demonstrates Strong Phase 3 Efficacy in Lupus, ...

10/17/2025Gilead's Kite Strikes Up to $1.64B In Vivo CAR-T Deal with China's Pre...

10/17/2025LEO Pharma's Anzupgo Cream NDA Accepted in China

10/17/2025Recent Executive Moves

Page:23/817 Total number of articles:24509: [First][<<] [21] [22] [23] [24] [25] [>>] [End]